Fibroblastic and Myofibroblastic Tumours
On this page
Direct answer
Fibroblastic and myofibroblastic tumours span the strangest spectrum in soft tissue pathology — from nodular fasciitis, a rapidly growing, mitosis-rich lesion that terrifies on microscopy yet self-heals once its USP6 rearrangement-driven cycle completes, to low-grade fibromyxoid sarcoma, a deceptively bland tumour that metastasises years later. The WHO 2020 (5th edition) framework separates benign self-limiting lesions (nodular and proliferative fasciitis, myositis ossificans), intermediate locally aggressive fibromatoses (desmoid, palmar and plantar fibromatosis), rarely metastasising entities (dermatofibrosarcoma protuberans, solitary fibrous tumour, inflammatory myofibroblastic tumour) and the frankly malignant fibrosarcomas, modern markers — beta-catenin, CD34, STAT6, MUC4, ALK — pinning identities that morphology alone could not.
What you must remember
- Nodular fasciitis: weeks-old painful subcutaneous nodule; plump tissue-culture spindled cells, keloidal collagen, microcysts with red cells, frequent normal mitoses; USP6 rearrangement (MYH11-USP6 classic) confirms and explains its self-limiting behaviour — local excision cures.
- Myositis ossificans: zonation is diagnosis — cellular centre, maturing woven bone rim; misreading the central mitotic activity as extraskeletal osteosarcoma is the classical error, and early biopsy before zonation develops is the trap window.
- Desmoid (aggressive fibromatosis): deep fascial-abdominal-wall tumour, uniform spindled cells in collagen, infiltrative margins; nuclear beta-catenin from CTNNB1 mutation (S45F portends higher recurrence), mesenteric desmoids complicating familial adenomatous polyposis; treatment increasingly front-loaded with NSAIDs-tamoxifen and surveillance rather than mutilating surgery. Superficial fibromatoses — palmar (Dupuytren contracture) and plantar (Ledderhose) — are managed functionally.
- DFSP: storiform dermal plaque infiltrating subcutis in a honeycomb pattern, CD34-strong, COL1A1-PDGFB fusion from t(17;22) — imatinib for unresectable or metastatic disease; fibrosarcomatous transformation upgrades risk.
- Solitary fibrous tumour: patternless architecture, staghorn vessels, CD34 and nuclear STAT6 (NAB2-STAT6 fusion); risk stratified by mitoses, necrosis, size and site — the label haemangiopericytoma is retired.
- Low-grade fibromyxoid sarcoma: alternating collagenised and myxoid zones with giant collagen rosettes, MUC4 positivity, FUS-CREB3L2 fusion — "deceptively bland, distant metastasis" is the one-line exam summary.
- Inflammatory myofibroblastic tumour: myofibroblasts in a lymphoplasmacytic backdrop, ALK rearrangements commoner in children and lung — crizotinib responsiveness makes ALK testing clinically decisive.
- Elastofibroma dorsi: elderly backs, subscapular; globular elastin fibres "saw-toothed" on elastin stain — presented as a one-mark differentiator from sarcoma in an elderly farmer.
Resolving a rapidly growing forearm nodule
A 29-year-old gym-goer develops a 3 cm tender forearm nodule over five weeks. FNA or core biopsy shows plump spindle cells with prominent nucleoli, scattered normal mitoses (up to a few per 10 HPF), extravasated erythrocytes in microcysts and a keloid-like collagen backdrop. The reflex fear is sarcoma. The resolution lies in the composite: growth measured in weeks, pain, small size, superficial plane, culture-like plumpness without atypical mitoses, and microcystic bleeding — nodular fasciitis. USP6 break-apart FISH confirms; marginal excision is both diagnosis and cure; transformation or metastasis does not occur.
Contrast the genuinely dangerous mimic: low-grade fibromyxoid sarcoma also affects young adults, is painless, deeply situated, and its bland spindle cells in swirling collagen read as "benign fibrous histiocytoma" on frozen section — but MUC4 positivity and the FUS fusion betray it, and metastases appear a decade later. The lesson both cases teach: tempo, depth and mitotic quality outweigh individual cytological features.
Where students slip
Two examination failures recur. First, grading mitoses as malignant per se — nodular fasciitis and myositis ossificans brandish mitoses while deserving conservative surgery; atypical mitoses, not mitotic counts alone, carry the malignant signal. Second, treating beta-catenin nuclear staining as desmoid-specific — it also marks many colorectal carcinomas and other WNT-activated tumours, so the stain is interpretive within morphology, a caveat examiners reward. The subcontinent viva favourite is Gardner-associated mesenteric desmoid: the abdominal-wall mass after colectomy in an FAP patient is desmoid until proven, and its CTNNB1-driven behaviour explains why trauma and surgery feed it.
Frequently asked questions
Which genetic finding defines nodular fasciitis?
A USP6 rearrangement, classically MYH11-USP6 — a self-limited transitory neoplasm that stops growing once the rearranged pathway exhausts.
What distinguishes desmoid tumours immunohistochemically?
Nuclear beta-catenin accumulation from CTNNB1 (or APC-related) pathway activation, with negative markers for GIST and smooth muscle.
Which fusion and drug define dermatofibrosarcoma protuberans?
COL1A1-PDGFB, treatable with the PDGFR inhibitor imatinib when unresectable or metastatic, complementing wide surgical excision.
Which stains identify solitary fibrous tumour?
CD34 positivity with nuclear STAT6 expression from the NAB2-STAT6 fusion — the combination that retired the term haemangiopericytoma.
Why is low-grade fibromyxoid sarcoma dangerous despite bland cytology?
It metastasises late and unpredictably; MUC4 staining and FUS-CREB3L2 fusion identification are what prevent dismissal as a benign fibrous lesion.